Global Cord Blood Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CORBF research report →
About the company
Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes.
- CEO
- Ting Zheng
- IPO
- 2007
- Employees
- 1,202
- HQ
- Central, HK
Price Chart
- Market Cap
- $127.35M
- P/E
- 1.56
- P/S
- 0.69
- P/B
- 0.16
- EV/EBITDA
- -8.83
- Div Yield
- 0.00%
- Gross Margin
- 85.26%
- Op Margin
- 48.97%
- Net Margin
- 40.30%
- ROE
- 10.82%
- ROIC
- 6.26%
- Revenue
- $1.24B · 7.21%
- Net Income
- $501.06M · -1.41%
- EPS
- $4.12 · -1.44%
- Op Income
- $608.87M
- FCF YoY
- -2.62%
- 52W High
- $1.75
- 52W Low
- $0.20
- 50D MA
- $0.94
- 200D MA
- $0.95
- Beta
- -0.77
- Avg Volume
- 15.46K
Get TickerSpark's AI analysis on CORBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CORBF coverage
Recent articles, reports, and earnings notes.
No research on CORBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CORBF report →Similar companies
Peers in the same neighborhood.